title: Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale.
abstract: Reprogramming of a limited number of human cell types has been achieved through ectopic expression of four transcription factors to yield induced pluripotent stem (iPS) cells that closely resemble human embryonic stem cells (ESCs). Here, we determined functional and epigenetic properties of iPS cells generated from human umbilical vein endothelial cells (HUVEC) by conventional method of direct reprogramming. Retroviral overexpression of four transcription factors resets HUVEC to the pluripotency. Human endothelial cell-derived iPS (endo-iPS) cells were similar to human ESCs in morphology, gene expression, in vitro and in vivo differentiation capacity. Endo-iPS cells were efficiently differentiated in vitro into endothelial cells. Using genome-wide methylation profiling we show that promoter elements of endothelial specific genes were methylated following reprogramming whereas pluripotency-related gene promoters were hypomethylated similar to levels observed in ESCs. Genome-wide methylation analysis of CpG sites located in the functional regions of over than 14,000 genes indicated that human endo-iPS cells were highly similar to human ES cells, although differences in methylation levels of 46 genes were found. Overall CpG methylation of promoter regions in the pluripotent cells was higher than in somatic. We also show that during reprogramming female human endo-iPS cells exhibited reactivation of the somatically silenced X chromosome. Our findings demonstrate that iPS cells can be generated from human endothelial cells and reprogramming resets epigenetic status of endothelial cells to pluripotency.
authors.affiliation: Vavilov Institute of General Genetics RAS and LKT Ltd., Moscow, Russia.
authors.forename: Maria A
authors.initials: MA
authors.lastname: Lagarkova
authors.forename: Maria V
authors.initials: MV
authors.lastname: Shutova
authors.forename: Alexandra N
authors.initials: AN
authors.lastname: Bogomazova
authors.forename: Ekaterina M
authors.initials: EM
authors.lastname: Vassina
authors.forename: Evgeny A
authors.initials: EA
authors.lastname: Glazov
authors.forename: Ping
authors.initials: P
authors.lastname: Zhang
authors.forename: Albert A
authors.initials: AA
authors.lastname: Rizvanov
authors.forename: Ilya V
authors.initials: IV
authors.lastname: Chestkov
authors.forename: Sergey L
authors.initials: SL
authors.lastname: Kiselev
mesh_terms: D002454:Cell Differentiation; D065150:Cellular Reprogramming; D041321:Chromosomes, Human, X; D018899:CpG Islands; D019175:DNA Methylation; D042783:Endothelial Cells / Q000166:cytology*; D004730:Endothelium, Vascular / Q000166:cytology; D044127:Epigenesis, Genetic; D005260:Female; D020869:Gene Expression Profiling; D023281:Genomics; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D007621:Karyotyping; D011401:Promoter Regions, Genetic; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D014157:Transcription Factors